Description

Key Characteristics

• Drug Affinity Complex (DAC) modification extends CJC-1295’s half-life well beyond the standard, non-DAC form
• Studied for sustained, rather than pulsatile, growth-hormone-axis stimulation
• Distinct research profile from the shorter-acting CJC-1295 used in combination blends

Primary Research Focus Areas

• Sustained GH-axis signaling
• Long-interval dosing protocol research
• Comparative pharmacokinetic studies against non-DAC GHRH analogs

Preparation & Storage

• Reconstitute with bacteriostatic water; dissolve gently without shaking
• Store unreconstituted powder at -20°C
• Refrigerate reconstituted solution at 2–8°C; use within 30 days

Research Chemical: NOT FOR HUMAN CONSUMPTION. For laboratory research and in vitro use only. Not FDA approved.